Appendix Efficacy and safety of treatments in cutaneous polyarteritis nodosa: a French observational retrospective study

Published: 29-06-2021| Version 1 | DOI: 10.17632/4896hc3w26.1
Contributor:
Thomas BETTUZZI

Description

Supplemental Table 1 Clinical and biological characteristics of patients with cutaneous polyarteritis nodosa (cPAN) at baseline (n=68). Supplemental Table 2 Univariable and multivariable analysis of factors associated with prescription of a conventional immunosuppressant, a biologic agent or systemic glucocorticoids at any time. Supplemental Table 3 Adverse events retrospectively identified in patients with cPAN by treatment regimen.  

Files